Global Agomelatine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression.
LPI (LP Information)' newest research report, the “Agomelatine Industry Forecast” looks at past sales and reviews total world Agomelatine sales in 2022, providing a comprehensive analysis by region and market sector of projected Agomelatine sales for 2023 through 2029. With Agomelatine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Agomelatine industry.
This Insight Report provides a comprehensive analysis of the global Agomelatine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Agomelatine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Agomelatine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Agomelatine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Agomelatine.
The global Agomelatine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Agomelatine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Agomelatine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Agomelatine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Agomelatine players cover Servier, Rovi Pharma, Novartis, Nectid Inc and Jiangsu Haosen Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Agomelatine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Agomelatine market?
What factors are driving Agomelatine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Agomelatine market opportunities vary by end market size?
How does Agomelatine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression.
LPI (LP Information)' newest research report, the “Agomelatine Industry Forecast” looks at past sales and reviews total world Agomelatine sales in 2022, providing a comprehensive analysis by region and market sector of projected Agomelatine sales for 2023 through 2029. With Agomelatine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Agomelatine industry.
This Insight Report provides a comprehensive analysis of the global Agomelatine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Agomelatine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Agomelatine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Agomelatine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Agomelatine.
The global Agomelatine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Agomelatine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Agomelatine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Agomelatine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Agomelatine players cover Servier, Rovi Pharma, Novartis, Nectid Inc and Jiangsu Haosen Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Agomelatine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Serotonin 2C Agonist
- Melatonin Receptor 2 Agonist
- Melatonin Receptor 1 Agonist
- Serotonin Receptor Agonist
- Serotonin 2C Receptor Antagonist
- Depression
- Obsessive Compulsive Disorder
- Sleep Disorders
- Generalized Anxiety Disorder
- Multiple Sclerosis
- Systemic Traumatic Pain
- Autism
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Servier
- Rovi Pharma
- Novartis
- Nectid Inc
- Jiangsu Haosen Pharmaceutical Group
What is the 10-year outlook for the global Agomelatine market?
What factors are driving Agomelatine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Agomelatine market opportunities vary by end market size?
How does Agomelatine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Agomelatine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Agomelatine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Agomelatine by Country/Region, 2018, 2022 & 2029
2.2 Agomelatine Segment by Type
2.2.1 Serotonin 2C Agonist
2.2.2 Melatonin Receptor 2 Agonist
2.2.3 Melatonin Receptor 1 Agonist
2.2.4 Serotonin Receptor Agonist
2.2.5 Serotonin 2C Receptor Antagonist
2.3 Agomelatine Sales by Type
2.3.1 Global Agomelatine Sales Market Share by Type (2018-2023)
2.3.2 Global Agomelatine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Agomelatine Sale Price by Type (2018-2023)
2.4 Agomelatine Segment by Application
2.4.1 Depression
2.4.2 Obsessive Compulsive Disorder
2.4.3 Sleep Disorders
2.4.4 Generalized Anxiety Disorder
2.4.5 Multiple Sclerosis
2.4.6 Systemic Traumatic Pain
2.4.7 Autism
2.4.8 Other
2.5 Agomelatine Sales by Application
2.5.1 Global Agomelatine Sale Market Share by Application (2018-2023)
2.5.2 Global Agomelatine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Agomelatine Sale Price by Application (2018-2023)
3 GLOBAL AGOMELATINE BY COMPANY
3.1 Global Agomelatine Breakdown Data by Company
3.1.1 Global Agomelatine Annual Sales by Company (2018-2023)
3.1.2 Global Agomelatine Sales Market Share by Company (2018-2023)
3.2 Global Agomelatine Annual Revenue by Company (2018-2023)
3.2.1 Global Agomelatine Revenue by Company (2018-2023)
3.2.2 Global Agomelatine Revenue Market Share by Company (2018-2023)
3.3 Global Agomelatine Sale Price by Company
3.4 Key Manufacturers Agomelatine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Agomelatine Product Location Distribution
3.4.2 Players Agomelatine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AGOMELATINE BY GEOGRAPHIC REGION
4.1 World Historic Agomelatine Market Size by Geographic Region (2018-2023)
4.1.1 Global Agomelatine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Agomelatine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Agomelatine Market Size by Country/Region (2018-2023)
4.2.1 Global Agomelatine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Agomelatine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Agomelatine Sales Growth
4.4 APAC Agomelatine Sales Growth
4.5 Europe Agomelatine Sales Growth
4.6 Middle East & Africa Agomelatine Sales Growth
5 AMERICAS
5.1 Americas Agomelatine Sales by Country
5.1.1 Americas Agomelatine Sales by Country (2018-2023)
5.1.2 Americas Agomelatine Revenue by Country (2018-2023)
5.2 Americas Agomelatine Sales by Type
5.3 Americas Agomelatine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Agomelatine Sales by Region
6.1.1 APAC Agomelatine Sales by Region (2018-2023)
6.1.2 APAC Agomelatine Revenue by Region (2018-2023)
6.2 APAC Agomelatine Sales by Type
6.3 APAC Agomelatine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Agomelatine by Country
7.1.1 Europe Agomelatine Sales by Country (2018-2023)
7.1.2 Europe Agomelatine Revenue by Country (2018-2023)
7.2 Europe Agomelatine Sales by Type
7.3 Europe Agomelatine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Agomelatine by Country
8.1.1 Middle East & Africa Agomelatine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Agomelatine Revenue by Country (2018-2023)
8.2 Middle East & Africa Agomelatine Sales by Type
8.3 Middle East & Africa Agomelatine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Agomelatine
10.3 Manufacturing Process Analysis of Agomelatine
10.4 Industry Chain Structure of Agomelatine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Agomelatine Distributors
11.3 Agomelatine Customer
12 WORLD FORECAST REVIEW FOR AGOMELATINE BY GEOGRAPHIC REGION
12.1 Global Agomelatine Market Size Forecast by Region
12.1.1 Global Agomelatine Forecast by Region (2024-2029)
12.1.2 Global Agomelatine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Agomelatine Forecast by Type
12.7 Global Agomelatine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Servier
13.1.1 Servier Company Information
13.1.2 Servier Agomelatine Product Portfolios and Specifications
13.1.3 Servier Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Servier Main Business Overview
13.1.5 Servier Latest Developments
13.2 Rovi Pharma
13.2.1 Rovi Pharma Company Information
13.2.2 Rovi Pharma Agomelatine Product Portfolios and Specifications
13.2.3 Rovi Pharma Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Rovi Pharma Main Business Overview
13.2.5 Rovi Pharma Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Agomelatine Product Portfolios and Specifications
13.3.3 Novartis Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Nectid Inc
13.4.1 Nectid Inc Company Information
13.4.2 Nectid Inc Agomelatine Product Portfolios and Specifications
13.4.3 Nectid Inc Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nectid Inc Main Business Overview
13.4.5 Nectid Inc Latest Developments
13.5 Jiangsu Haosen Pharmaceutical Group
13.5.1 Jiangsu Haosen Pharmaceutical Group Company Information
13.5.2 Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolios and Specifications
13.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview
13.5.5 Jiangsu Haosen Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Agomelatine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Agomelatine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Agomelatine by Country/Region, 2018, 2022 & 2029
2.2 Agomelatine Segment by Type
2.2.1 Serotonin 2C Agonist
2.2.2 Melatonin Receptor 2 Agonist
2.2.3 Melatonin Receptor 1 Agonist
2.2.4 Serotonin Receptor Agonist
2.2.5 Serotonin 2C Receptor Antagonist
2.3 Agomelatine Sales by Type
2.3.1 Global Agomelatine Sales Market Share by Type (2018-2023)
2.3.2 Global Agomelatine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Agomelatine Sale Price by Type (2018-2023)
2.4 Agomelatine Segment by Application
2.4.1 Depression
2.4.2 Obsessive Compulsive Disorder
2.4.3 Sleep Disorders
2.4.4 Generalized Anxiety Disorder
2.4.5 Multiple Sclerosis
2.4.6 Systemic Traumatic Pain
2.4.7 Autism
2.4.8 Other
2.5 Agomelatine Sales by Application
2.5.1 Global Agomelatine Sale Market Share by Application (2018-2023)
2.5.2 Global Agomelatine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Agomelatine Sale Price by Application (2018-2023)
3 GLOBAL AGOMELATINE BY COMPANY
3.1 Global Agomelatine Breakdown Data by Company
3.1.1 Global Agomelatine Annual Sales by Company (2018-2023)
3.1.2 Global Agomelatine Sales Market Share by Company (2018-2023)
3.2 Global Agomelatine Annual Revenue by Company (2018-2023)
3.2.1 Global Agomelatine Revenue by Company (2018-2023)
3.2.2 Global Agomelatine Revenue Market Share by Company (2018-2023)
3.3 Global Agomelatine Sale Price by Company
3.4 Key Manufacturers Agomelatine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Agomelatine Product Location Distribution
3.4.2 Players Agomelatine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AGOMELATINE BY GEOGRAPHIC REGION
4.1 World Historic Agomelatine Market Size by Geographic Region (2018-2023)
4.1.1 Global Agomelatine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Agomelatine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Agomelatine Market Size by Country/Region (2018-2023)
4.2.1 Global Agomelatine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Agomelatine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Agomelatine Sales Growth
4.4 APAC Agomelatine Sales Growth
4.5 Europe Agomelatine Sales Growth
4.6 Middle East & Africa Agomelatine Sales Growth
5 AMERICAS
5.1 Americas Agomelatine Sales by Country
5.1.1 Americas Agomelatine Sales by Country (2018-2023)
5.1.2 Americas Agomelatine Revenue by Country (2018-2023)
5.2 Americas Agomelatine Sales by Type
5.3 Americas Agomelatine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Agomelatine Sales by Region
6.1.1 APAC Agomelatine Sales by Region (2018-2023)
6.1.2 APAC Agomelatine Revenue by Region (2018-2023)
6.2 APAC Agomelatine Sales by Type
6.3 APAC Agomelatine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Agomelatine by Country
7.1.1 Europe Agomelatine Sales by Country (2018-2023)
7.1.2 Europe Agomelatine Revenue by Country (2018-2023)
7.2 Europe Agomelatine Sales by Type
7.3 Europe Agomelatine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Agomelatine by Country
8.1.1 Middle East & Africa Agomelatine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Agomelatine Revenue by Country (2018-2023)
8.2 Middle East & Africa Agomelatine Sales by Type
8.3 Middle East & Africa Agomelatine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Agomelatine
10.3 Manufacturing Process Analysis of Agomelatine
10.4 Industry Chain Structure of Agomelatine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Agomelatine Distributors
11.3 Agomelatine Customer
12 WORLD FORECAST REVIEW FOR AGOMELATINE BY GEOGRAPHIC REGION
12.1 Global Agomelatine Market Size Forecast by Region
12.1.1 Global Agomelatine Forecast by Region (2024-2029)
12.1.2 Global Agomelatine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Agomelatine Forecast by Type
12.7 Global Agomelatine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Servier
13.1.1 Servier Company Information
13.1.2 Servier Agomelatine Product Portfolios and Specifications
13.1.3 Servier Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Servier Main Business Overview
13.1.5 Servier Latest Developments
13.2 Rovi Pharma
13.2.1 Rovi Pharma Company Information
13.2.2 Rovi Pharma Agomelatine Product Portfolios and Specifications
13.2.3 Rovi Pharma Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Rovi Pharma Main Business Overview
13.2.5 Rovi Pharma Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Agomelatine Product Portfolios and Specifications
13.3.3 Novartis Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Nectid Inc
13.4.1 Nectid Inc Company Information
13.4.2 Nectid Inc Agomelatine Product Portfolios and Specifications
13.4.3 Nectid Inc Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nectid Inc Main Business Overview
13.4.5 Nectid Inc Latest Developments
13.5 Jiangsu Haosen Pharmaceutical Group
13.5.1 Jiangsu Haosen Pharmaceutical Group Company Information
13.5.2 Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolios and Specifications
13.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview
13.5.5 Jiangsu Haosen Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Agomelatine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Agomelatine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Serotonin 2C Agonist
Table 4. Major Players of Melatonin Receptor 2 Agonist
Table 5. Major Players of Melatonin Receptor 1 Agonist
Table 6. Major Players of Serotonin Receptor Agonist
Table 7. Major Players of Serotonin 2C Receptor Antagonist
Table 8. Global Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 9. Global Agomelatine Sales Market Share by Type (2018-2023)
Table 10. Global Agomelatine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Agomelatine Revenue Market Share by Type (2018-2023)
Table 12. Global Agomelatine Sale Price by Type (2018-2023) & (US$/Pcs)
Table 13. Global Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 14. Global Agomelatine Sales Market Share by Application (2018-2023)
Table 15. Global Agomelatine Revenue by Application (2018-2023)
Table 16. Global Agomelatine Revenue Market Share by Application (2018-2023)
Table 17. Global Agomelatine Sale Price by Application (2018-2023) & (US$/Pcs)
Table 18. Global Agomelatine Sales by Company (2018-2023) & (M Pcs)
Table 19. Global Agomelatine Sales Market Share by Company (2018-2023)
Table 20. Global Agomelatine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Agomelatine Revenue Market Share by Company (2018-2023)
Table 22. Global Agomelatine Sale Price by Company (2018-2023) & (US$/Pcs)
Table 23. Key Manufacturers Agomelatine Producing Area Distribution and Sales Area
Table 24. Players Agomelatine Products Offered
Table 25. Agomelatine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Agomelatine Sales by Geographic Region (2018-2023) & (M Pcs)
Table 29. Global Agomelatine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Agomelatine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Agomelatine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Agomelatine Sales by Country/Region (2018-2023) & (M Pcs)
Table 33. Global Agomelatine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Agomelatine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Agomelatine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Agomelatine Sales by Country (2018-2023) & (M Pcs)
Table 37. Americas Agomelatine Sales Market Share by Country (2018-2023)
Table 38. Americas Agomelatine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Agomelatine Revenue Market Share by Country (2018-2023)
Table 40. Americas Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 41. Americas Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 42. APAC Agomelatine Sales by Region (2018-2023) & (M Pcs)
Table 43. APAC Agomelatine Sales Market Share by Region (2018-2023)
Table 44. APAC Agomelatine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Agomelatine Revenue Market Share by Region (2018-2023)
Table 46. APAC Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 47. APAC Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 48. Europe Agomelatine Sales by Country (2018-2023) & (M Pcs)
Table 49. Europe Agomelatine Sales Market Share by Country (2018-2023)
Table 50. Europe Agomelatine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Agomelatine Revenue Market Share by Country (2018-2023)
Table 52. Europe Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 53. Europe Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 54. Middle East & Africa Agomelatine Sales by Country (2018-2023) & (M Pcs)
Table 55. Middle East & Africa Agomelatine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Agomelatine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Agomelatine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 59. Middle East & Africa Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Agomelatine
Table 61. Key Market Challenges & Risks of Agomelatine
Table 62. Key Industry Trends of Agomelatine
Table 63. Agomelatine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Agomelatine Distributors List
Table 66. Agomelatine Customer List
Table 67. Global Agomelatine Sales Forecast by Region (2024-2029) & (M Pcs)
Table 68. Global Agomelatine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Agomelatine Sales Forecast by Country (2024-2029) & (M Pcs)
Table 70. Americas Agomelatine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Agomelatine Sales Forecast by Region (2024-2029) & (M Pcs)
Table 72. APAC Agomelatine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Agomelatine Sales Forecast by Country (2024-2029) & (M Pcs)
Table 74. Europe Agomelatine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Agomelatine Sales Forecast by Country (2024-2029) & (M Pcs)
Table 76. Middle East & Africa Agomelatine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Agomelatine Sales Forecast by Type (2024-2029) & (M Pcs)
Table 78. Global Agomelatine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Agomelatine Sales Forecast by Application (2024-2029) & (M Pcs)
Table 80. Global Agomelatine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Servier Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 82. Servier Agomelatine Product Portfolios and Specifications
Table 83. Servier Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 84. Servier Main Business
Table 85. Servier Latest Developments
Table 86. Rovi Pharma Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 87. Rovi Pharma Agomelatine Product Portfolios and Specifications
Table 88. Rovi Pharma Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 89. Rovi Pharma Main Business
Table 90. Rovi Pharma Latest Developments
Table 91. Novartis Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Agomelatine Product Portfolios and Specifications
Table 93. Novartis Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Nectid Inc Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 97. Nectid Inc Agomelatine Product Portfolios and Specifications
Table 98. Nectid Inc Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 99. Nectid Inc Main Business
Table 100. Nectid Inc Latest Developments
Table 101. Jiangsu Haosen Pharmaceutical Group Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 102. Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolios and Specifications
Table 103. Jiangsu Haosen Pharmaceutical Group Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 104. Jiangsu Haosen Pharmaceutical Group Main Business
Table 105. Jiangsu Haosen Pharmaceutical Group Latest Developments
Table 1. Agomelatine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Agomelatine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Serotonin 2C Agonist
Table 4. Major Players of Melatonin Receptor 2 Agonist
Table 5. Major Players of Melatonin Receptor 1 Agonist
Table 6. Major Players of Serotonin Receptor Agonist
Table 7. Major Players of Serotonin 2C Receptor Antagonist
Table 8. Global Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 9. Global Agomelatine Sales Market Share by Type (2018-2023)
Table 10. Global Agomelatine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Agomelatine Revenue Market Share by Type (2018-2023)
Table 12. Global Agomelatine Sale Price by Type (2018-2023) & (US$/Pcs)
Table 13. Global Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 14. Global Agomelatine Sales Market Share by Application (2018-2023)
Table 15. Global Agomelatine Revenue by Application (2018-2023)
Table 16. Global Agomelatine Revenue Market Share by Application (2018-2023)
Table 17. Global Agomelatine Sale Price by Application (2018-2023) & (US$/Pcs)
Table 18. Global Agomelatine Sales by Company (2018-2023) & (M Pcs)
Table 19. Global Agomelatine Sales Market Share by Company (2018-2023)
Table 20. Global Agomelatine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Agomelatine Revenue Market Share by Company (2018-2023)
Table 22. Global Agomelatine Sale Price by Company (2018-2023) & (US$/Pcs)
Table 23. Key Manufacturers Agomelatine Producing Area Distribution and Sales Area
Table 24. Players Agomelatine Products Offered
Table 25. Agomelatine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Agomelatine Sales by Geographic Region (2018-2023) & (M Pcs)
Table 29. Global Agomelatine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Agomelatine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Agomelatine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Agomelatine Sales by Country/Region (2018-2023) & (M Pcs)
Table 33. Global Agomelatine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Agomelatine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Agomelatine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Agomelatine Sales by Country (2018-2023) & (M Pcs)
Table 37. Americas Agomelatine Sales Market Share by Country (2018-2023)
Table 38. Americas Agomelatine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Agomelatine Revenue Market Share by Country (2018-2023)
Table 40. Americas Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 41. Americas Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 42. APAC Agomelatine Sales by Region (2018-2023) & (M Pcs)
Table 43. APAC Agomelatine Sales Market Share by Region (2018-2023)
Table 44. APAC Agomelatine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Agomelatine Revenue Market Share by Region (2018-2023)
Table 46. APAC Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 47. APAC Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 48. Europe Agomelatine Sales by Country (2018-2023) & (M Pcs)
Table 49. Europe Agomelatine Sales Market Share by Country (2018-2023)
Table 50. Europe Agomelatine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Agomelatine Revenue Market Share by Country (2018-2023)
Table 52. Europe Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 53. Europe Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 54. Middle East & Africa Agomelatine Sales by Country (2018-2023) & (M Pcs)
Table 55. Middle East & Africa Agomelatine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Agomelatine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Agomelatine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Agomelatine Sales by Type (2018-2023) & (M Pcs)
Table 59. Middle East & Africa Agomelatine Sales by Application (2018-2023) & (M Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Agomelatine
Table 61. Key Market Challenges & Risks of Agomelatine
Table 62. Key Industry Trends of Agomelatine
Table 63. Agomelatine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Agomelatine Distributors List
Table 66. Agomelatine Customer List
Table 67. Global Agomelatine Sales Forecast by Region (2024-2029) & (M Pcs)
Table 68. Global Agomelatine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Agomelatine Sales Forecast by Country (2024-2029) & (M Pcs)
Table 70. Americas Agomelatine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Agomelatine Sales Forecast by Region (2024-2029) & (M Pcs)
Table 72. APAC Agomelatine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Agomelatine Sales Forecast by Country (2024-2029) & (M Pcs)
Table 74. Europe Agomelatine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Agomelatine Sales Forecast by Country (2024-2029) & (M Pcs)
Table 76. Middle East & Africa Agomelatine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Agomelatine Sales Forecast by Type (2024-2029) & (M Pcs)
Table 78. Global Agomelatine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Agomelatine Sales Forecast by Application (2024-2029) & (M Pcs)
Table 80. Global Agomelatine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Servier Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 82. Servier Agomelatine Product Portfolios and Specifications
Table 83. Servier Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 84. Servier Main Business
Table 85. Servier Latest Developments
Table 86. Rovi Pharma Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 87. Rovi Pharma Agomelatine Product Portfolios and Specifications
Table 88. Rovi Pharma Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 89. Rovi Pharma Main Business
Table 90. Rovi Pharma Latest Developments
Table 91. Novartis Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Agomelatine Product Portfolios and Specifications
Table 93. Novartis Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Nectid Inc Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 97. Nectid Inc Agomelatine Product Portfolios and Specifications
Table 98. Nectid Inc Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 99. Nectid Inc Main Business
Table 100. Nectid Inc Latest Developments
Table 101. Jiangsu Haosen Pharmaceutical Group Basic Information, Agomelatine Manufacturing Base, Sales Area and Its Competitors
Table 102. Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolios and Specifications
Table 103. Jiangsu Haosen Pharmaceutical Group Agomelatine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 104. Jiangsu Haosen Pharmaceutical Group Main Business
Table 105. Jiangsu Haosen Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Agomelatine
Figure 2. Agomelatine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Agomelatine Sales Growth Rate 2018-2029 (M Pcs)
Figure 7. Global Agomelatine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Agomelatine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Serotonin 2C Agonist
Figure 10. Product Picture of Melatonin Receptor 2 Agonist
Figure 11. Product Picture of Melatonin Receptor 1 Agonist
Figure 12. Product Picture of Serotonin Receptor Agonist
Figure 13. Product Picture of Serotonin 2C Receptor Antagonist
Figure 14. Global Agomelatine Sales Market Share by Type in 2022
Figure 15. Global Agomelatine Revenue Market Share by Type (2018-2023)
Figure 16. Agomelatine Consumed in Depression
Figure 17. Global Agomelatine Market: Depression (2018-2023) & (M Pcs)
Figure 18. Agomelatine Consumed in Obsessive Compulsive Disorder
Figure 19. Global Agomelatine Market: Obsessive Compulsive Disorder (2018-2023) & (M Pcs)
Figure 20. Agomelatine Consumed in Sleep Disorders
Figure 21. Global Agomelatine Market: Sleep Disorders (2018-2023) & (M Pcs)
Figure 22. Agomelatine Consumed in Generalized Anxiety Disorder
Figure 23. Global Agomelatine Market: Generalized Anxiety Disorder (2018-2023) & (M Pcs)
Figure 24. Agomelatine Consumed in Multiple Sclerosis
Figure 25. Global Agomelatine Market: Multiple Sclerosis (2018-2023) & (M Pcs)
Figure 26. Agomelatine Consumed in Systemic Traumatic Pain
Figure 27. Global Agomelatine Market: Systemic Traumatic Pain (2018-2023) & (M Pcs)
Figure 28. Agomelatine Consumed in Autism
Figure 29. Global Agomelatine Market: Autism (2018-2023) & (M Pcs)
Figure 30. Agomelatine Consumed in Other
Figure 31. Global Agomelatine Market: Other (2018-2023) & (M Pcs)
Figure 32. Global Agomelatine Sales Market Share by Application (2022)
Figure 33. Global Agomelatine Revenue Market Share by Application in 2022
Figure 34. Agomelatine Sales Market by Company in 2022 (M Pcs)
Figure 35. Global Agomelatine Sales Market Share by Company in 2022
Figure 36. Agomelatine Revenue Market by Company in 2022 ($ Million)
Figure 37. Global Agomelatine Revenue Market Share by Company in 2022
Figure 38. Global Agomelatine Sales Market Share by Geographic Region (2018-2023)
Figure 39. Global Agomelatine Revenue Market Share by Geographic Region in 2022
Figure 40. Americas Agomelatine Sales 2018-2023 (M Pcs)
Figure 41. Americas Agomelatine Revenue 2018-2023 ($ Millions)
Figure 42. APAC Agomelatine Sales 2018-2023 (M Pcs)
Figure 43. APAC Agomelatine Revenue 2018-2023 ($ Millions)
Figure 44. Europe Agomelatine Sales 2018-2023 (M Pcs)
Figure 45. Europe Agomelatine Revenue 2018-2023 ($ Millions)
Figure 46. Middle East & Africa Agomelatine Sales 2018-2023 (M Pcs)
Figure 47. Middle East & Africa Agomelatine Revenue 2018-2023 ($ Millions)
Figure 48. Americas Agomelatine Sales Market Share by Country in 2022
Figure 49. Americas Agomelatine Revenue Market Share by Country in 2022
Figure 50. Americas Agomelatine Sales Market Share by Type (2018-2023)
Figure 51. Americas Agomelatine Sales Market Share by Application (2018-2023)
Figure 52. United States Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Canada Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Mexico Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Brazil Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 56. APAC Agomelatine Sales Market Share by Region in 2022
Figure 57. APAC Agomelatine Revenue Market Share by Regions in 2022
Figure 58. APAC Agomelatine Sales Market Share by Type (2018-2023)
Figure 59. APAC Agomelatine Sales Market Share by Application (2018-2023)
Figure 60. China Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Japan Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 62. South Korea Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Southeast Asia Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 64. India Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Australia Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 66. China Taiwan Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Europe Agomelatine Sales Market Share by Country in 2022
Figure 68. Europe Agomelatine Revenue Market Share by Country in 2022
Figure 69. Europe Agomelatine Sales Market Share by Type (2018-2023)
Figure 70. Europe Agomelatine Sales Market Share by Application (2018-2023)
Figure 71. Germany Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 72. France Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 73. UK Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Italy Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Russia Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Middle East & Africa Agomelatine Sales Market Share by Country in 2022
Figure 77. Middle East & Africa Agomelatine Revenue Market Share by Country in 2022
Figure 78. Middle East & Africa Agomelatine Sales Market Share by Type (2018-2023)
Figure 79. Middle East & Africa Agomelatine Sales Market Share by Application (2018-2023)
Figure 80. Egypt Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 81. South Africa Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 82. Israel Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 83. Turkey Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 84. GCC Country Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 85. Manufacturing Cost Structure Analysis of Agomelatine in 2022
Figure 86. Manufacturing Process Analysis of Agomelatine
Figure 87. Industry Chain Structure of Agomelatine
Figure 88. Channels of Distribution
Figure 89. Global Agomelatine Sales Market Forecast by Region (2024-2029)
Figure 90. Global Agomelatine Revenue Market Share Forecast by Region (2024-2029)
Figure 91. Global Agomelatine Sales Market Share Forecast by Type (2024-2029)
Figure 92. Global Agomelatine Revenue Market Share Forecast by Type (2024-2029)
Figure 93. Global Agomelatine Sales Market Share Forecast by Application (2024-2029)
Figure 94. Global Agomelatine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Agomelatine
Figure 2. Agomelatine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Agomelatine Sales Growth Rate 2018-2029 (M Pcs)
Figure 7. Global Agomelatine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Agomelatine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Serotonin 2C Agonist
Figure 10. Product Picture of Melatonin Receptor 2 Agonist
Figure 11. Product Picture of Melatonin Receptor 1 Agonist
Figure 12. Product Picture of Serotonin Receptor Agonist
Figure 13. Product Picture of Serotonin 2C Receptor Antagonist
Figure 14. Global Agomelatine Sales Market Share by Type in 2022
Figure 15. Global Agomelatine Revenue Market Share by Type (2018-2023)
Figure 16. Agomelatine Consumed in Depression
Figure 17. Global Agomelatine Market: Depression (2018-2023) & (M Pcs)
Figure 18. Agomelatine Consumed in Obsessive Compulsive Disorder
Figure 19. Global Agomelatine Market: Obsessive Compulsive Disorder (2018-2023) & (M Pcs)
Figure 20. Agomelatine Consumed in Sleep Disorders
Figure 21. Global Agomelatine Market: Sleep Disorders (2018-2023) & (M Pcs)
Figure 22. Agomelatine Consumed in Generalized Anxiety Disorder
Figure 23. Global Agomelatine Market: Generalized Anxiety Disorder (2018-2023) & (M Pcs)
Figure 24. Agomelatine Consumed in Multiple Sclerosis
Figure 25. Global Agomelatine Market: Multiple Sclerosis (2018-2023) & (M Pcs)
Figure 26. Agomelatine Consumed in Systemic Traumatic Pain
Figure 27. Global Agomelatine Market: Systemic Traumatic Pain (2018-2023) & (M Pcs)
Figure 28. Agomelatine Consumed in Autism
Figure 29. Global Agomelatine Market: Autism (2018-2023) & (M Pcs)
Figure 30. Agomelatine Consumed in Other
Figure 31. Global Agomelatine Market: Other (2018-2023) & (M Pcs)
Figure 32. Global Agomelatine Sales Market Share by Application (2022)
Figure 33. Global Agomelatine Revenue Market Share by Application in 2022
Figure 34. Agomelatine Sales Market by Company in 2022 (M Pcs)
Figure 35. Global Agomelatine Sales Market Share by Company in 2022
Figure 36. Agomelatine Revenue Market by Company in 2022 ($ Million)
Figure 37. Global Agomelatine Revenue Market Share by Company in 2022
Figure 38. Global Agomelatine Sales Market Share by Geographic Region (2018-2023)
Figure 39. Global Agomelatine Revenue Market Share by Geographic Region in 2022
Figure 40. Americas Agomelatine Sales 2018-2023 (M Pcs)
Figure 41. Americas Agomelatine Revenue 2018-2023 ($ Millions)
Figure 42. APAC Agomelatine Sales 2018-2023 (M Pcs)
Figure 43. APAC Agomelatine Revenue 2018-2023 ($ Millions)
Figure 44. Europe Agomelatine Sales 2018-2023 (M Pcs)
Figure 45. Europe Agomelatine Revenue 2018-2023 ($ Millions)
Figure 46. Middle East & Africa Agomelatine Sales 2018-2023 (M Pcs)
Figure 47. Middle East & Africa Agomelatine Revenue 2018-2023 ($ Millions)
Figure 48. Americas Agomelatine Sales Market Share by Country in 2022
Figure 49. Americas Agomelatine Revenue Market Share by Country in 2022
Figure 50. Americas Agomelatine Sales Market Share by Type (2018-2023)
Figure 51. Americas Agomelatine Sales Market Share by Application (2018-2023)
Figure 52. United States Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Canada Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Mexico Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Brazil Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 56. APAC Agomelatine Sales Market Share by Region in 2022
Figure 57. APAC Agomelatine Revenue Market Share by Regions in 2022
Figure 58. APAC Agomelatine Sales Market Share by Type (2018-2023)
Figure 59. APAC Agomelatine Sales Market Share by Application (2018-2023)
Figure 60. China Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Japan Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 62. South Korea Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Southeast Asia Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 64. India Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Australia Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 66. China Taiwan Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Europe Agomelatine Sales Market Share by Country in 2022
Figure 68. Europe Agomelatine Revenue Market Share by Country in 2022
Figure 69. Europe Agomelatine Sales Market Share by Type (2018-2023)
Figure 70. Europe Agomelatine Sales Market Share by Application (2018-2023)
Figure 71. Germany Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 72. France Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 73. UK Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Italy Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Russia Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Middle East & Africa Agomelatine Sales Market Share by Country in 2022
Figure 77. Middle East & Africa Agomelatine Revenue Market Share by Country in 2022
Figure 78. Middle East & Africa Agomelatine Sales Market Share by Type (2018-2023)
Figure 79. Middle East & Africa Agomelatine Sales Market Share by Application (2018-2023)
Figure 80. Egypt Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 81. South Africa Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 82. Israel Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 83. Turkey Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 84. GCC Country Agomelatine Revenue Growth 2018-2023 ($ Millions)
Figure 85. Manufacturing Cost Structure Analysis of Agomelatine in 2022
Figure 86. Manufacturing Process Analysis of Agomelatine
Figure 87. Industry Chain Structure of Agomelatine
Figure 88. Channels of Distribution
Figure 89. Global Agomelatine Sales Market Forecast by Region (2024-2029)
Figure 90. Global Agomelatine Revenue Market Share Forecast by Region (2024-2029)
Figure 91. Global Agomelatine Sales Market Share Forecast by Type (2024-2029)
Figure 92. Global Agomelatine Revenue Market Share Forecast by Type (2024-2029)
Figure 93. Global Agomelatine Sales Market Share Forecast by Application (2024-2029)
Figure 94. Global Agomelatine Revenue Market Share Forecast by Application (2024-2029)
